About RiconPharma
RiconPharma is a Healthcare company based in Denville (United States) founded in 2008 by Raj Devalapalli and Mukti Gande. A CRO specializing in novel drug formulations and delivery systems. It operates on a B2B model. The company has 87 employees. Its chief executive, as recorded, is Raj Devalapalli. Its Indian entity Riconpharma India Private Limited reported revenue of ₹27.30 Cr. Its focus areas include Pharmaceuticals, Drug Development and Formulations and Delivery.
Company details
RiconPharma, based in Denville, focuses on providing healthcare solutions, producing pharmaceutical products, drug development, and formulations and delivery. A CRO specializing in novel drug formulations and delivery systems. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Denville, United States
- Employees 87
- Founders Raj Devalapalli, Mukti Gande
- SectorsHealthcare
- Website riconpharma.com
- Social Facebook
- Legal Name Riconpharma India Private Limited
- Date of Incorporation 03 Mar, 2009
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹27.30 Cr
FY 2024 · +24% YoY
- Indian entity net profit₹88.1 Lakh
FY 2024 · 3% margin
- Indian entity EBITDA₹4.13 Cr
FY 2024 · 15% margin
- Employee Count87
Associated legal entities of RiconPharma
RiconPharma operates through Riconpharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Riconpharma India Private Limited CIN U24232TG2009PTC062946 | Active | 03 Mar 2009 | Hyderabad, Telangana | ₹27.3 Cr | 87 | 3 | View details |
Board of directors of Riconpharma India Private Limited (RiconPharma)
Riconpharma India Private Limited is the primary company behind RiconPharma. The board of Riconpharma India Private Limited currently have 3 directors; the longest-serving is Valiveti Brahmaji, appointed in 2014. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Valiveti Brahmaji DIN 00079255 | Director | 01 Oct 2014 | 12 yrs | Riconpharma India Private Limited |
| Mukteeshwar Gande DIN 00278202 | Director | 12 Feb 2015 | 11 yrs 8 mo | Riconpharma India Private Limited |
| Nageswara Rao Muntha Venkata DIN 07004705 | Director | 23 Jan 2018 | 8 yrs 9 mo | Riconpharma India Private Limited |
People of RiconPharma
2 people are tracked at RiconPharma (2 in leadership); the tracked headcount is 87.
| Name | Role | Group |
|---|---|---|
Raj Devalapalli | Co-Founder, CEO | Leadership |
Mukti Gande | Co-Founder, CSO | Leadership |
Complete people profiles for RiconPharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of RiconPharma
Figures of Riconpharma India Private Limited, the primary company behind RiconPharma, for FY 2024. Revenue was ₹27.30 Cr (+24% year on year). Net profit was ₹88.1 Lakh (3% margin). EBITDA was ₹4.13 Cr (15% margin). Revenue has grown at a compounded annual rate of +15% over three years and +3% over five years.
- ₹27.30 CrRevenue · FY 2024 · +24% YoY
- ₹88.1 LakhNet profit · 3% margin
- ₹4.13 CrEBITDA · 15% margin
- ₹4.83 CrPaid-up capital
- 87Employees (provident fund records)
- +15%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Riconpharma India Private Limited are on its company page.
Detailed financial statements for RiconPharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as RiconPharma (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RiconPharma
RiconPharma was founded in 2008.
RiconPharma is headquartered in Denville, United States. It is registered at Denville, New Jersey, United States.
Raj Devalapalli is the CEO of RiconPharma, as recorded in our data. They have also founded this company.
RiconPharma has 87 employees.
The primary company behind RiconPharma, Riconpharma India Private Limited, reported revenue of ₹27.30 Cr for FY 2024, up 24% year on year.
RiconPharma, based in Denville, focuses on providing healthcare solutions, producing pharmaceutical products, drug development, and formulations and delivery. A CRO specializing in novel drug formulations and delivery systems. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
RiconPharma operates through Riconpharma India Private Limited.
The legal entities of RiconPharma currently have 3 directors, including Valiveti Brahmaji, Mukteeshwar Gande, Nageswara Rao Muntha Venkata.